1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Key Pharma News 02 NOVEMBER 2015

Key Pharma News 02 NOVEMBER 2015

  • November 2015
  • -
  • Espicom Business Intelligence
  • -
  • 19 pages

Industry Trend Analysis - Greater Knowledge Application Boosting Cancer Vaccine Potential
Industry Trend Analysis - Optimal Legacy/Innovation Balance To Maintain Roche's Growth Trajectory
Industry Trend Analysis - Pfizer Entering Transformational Period
Industry Trend Analysis - Daiichi's De-Diversification Efforts To Secure Long-Term Growth
Industry Trend Analysis - Perrigo Management Shores Up Defences Ahead Of Mylan Bid Deadline
Industry Trend Analysis - Biogen's Restructuring Will Lead To A Broader Product Base
Industry Trend Analysis - US To Become Sandoz' Dominant Market
Industry Trend Analysis - Teva's Revenues Fall But Copaxone And Specialty Revenues Provide Encouragement
Industry Brief - Allergan Confirms Business Combination Transaction Discussions With Pfizer
Industry Brief - Novartis Foundation Launch New Hypertension Programme In Ghana
Industry Brief - Cresemba Gains EU Approval For Invasive Aspergillosis/Mucormycosis
Industry Brief - FDA Approves BI's Praxbind As Reversal Agent For Pradaxa
Industry Brief - FDA Approves Dyanavel XR For ADHD
Industry Trend Analysis - Irish Guidance Highlights Common Themes In Emerging Biosimilar Market
Industry Trend Analysis - New CHMP Approval Recommendations Will Catalyse Cosentyx Blockbuster Status
Industry Trend Analysis - Collaborative Approach Will Bolster AstraZeneca/Lilly's Immuno-Oncology Presence
Industry Brief - FDA Requires Additional Study For AstraZeneca's Sxagilptin/Dapagliflozin
Industry Trend Analysis - Biogen To Refocus After Poor Tysabri Results In SPMS

Table Of Contents

Key Pharma News 02 NOVEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.